Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

Publication | Closed Access

DOI

481

Citations

References

2010

Year

Christian T. Ruff, Robert P. Giugliano, Elliott M. Antman, Sharon Crugnale, Tomás S. Bocanegra, Michele Mercuri, James Hanyok, Indravadan Patel, Minggao Shi, Dan Salazar,

American Heart Journal

ThrombosisCardiovascular DiseaseMedicineCardiovascular PharmacologyAnticoagulantPharmacotherapyCoagulopathyAtrial FibrillationEngage Af–timi 48Effective AnticoagulationPharmacologyPublic HealthCardiology